Beyond Air, Inc. (NASDAQ:XAIR) Financial Overview and Market Position

Beyond Air, Inc. (NASDAQ:XAIR) is a medical device and biopharmaceutical company focused on developing innovative solutions for respiratory diseases. The company is known for its LungFit® PH system, which delivers nitric oxide for the treatment of various respiratory conditions. XAIR competes with other companies in the respiratory care market, striving to expand its global reach and product offerings.

On June 17, 2025, XAIR reported an earnings per share (EPS) of -$0.09, surpassing the estimated EPS of -$0.14. Despite this positive surprise, the company's revenue of approximately $1.15 million fell short of the expected $1.39 million. This mixed performance led to a decline in XAIR's stock price, as highlighted by the company's fourth-quarter results announcement. The company anticipates at least $1.7 million in revenue for the quarter ending June 30, 2025, and has set a revenue guidance of $12 to $16 million for the full fiscal year 2026.

This growth is supported by international distribution partnerships, providing access to markets representing over 2 billion lives. XAIR's financial metrics reveal a price-to-sales ratio of approximately 8.14, indicating that investors are willing to pay over eight times the company's sales for its stock. The enterprise value to sales ratio is about 7.28, suggesting a slightly lower valuation when considering the company's debt and cash. The debt-to-equity ratio is relatively low at 0.11, reflecting a conservative use of debt in its capital structure.

Despite these positive aspects, XAIR faces challenges with profitability. The negative price-to-earnings ratio and earnings yield indicate that the company is currently not profitable. Additionally, the negative enterprise value to operating cash flow ratio suggests difficulties in generating positive cash flow from operations. However, the company's strong liquidity position, with a current ratio of 3.56, implies that it can cover its current liabilities with its current assets.